Navigation Links
Thoratec Announces Appointment of Paul LaViolette to Board of Directors
Date:5/15/2009

PLEASANTON, Calif., May 15 /PRNewswire-FirstCall/ -- Thoratec Corporation (Nasdaq: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced the election of Paul A. LaViolette, the former chief operating officer of Boston Scientific, to its board of directors. LaViolette was elected by the company's shareholders at the company's annual shareholders' meeting on May 13 and brings the number of the company's directors to eight.

LaViolette spent 14 years at Boston Scientific and served as chief operating officer from 2004-2008. Before that, he was senior vice president and group president for several of the company's divisions and its international operations. He was formerly associated with C.R. Bard, Inc., where he held senior management positions and led several of the company's divisions.

"We are pleased to have someone with Paul's broad cardiovascular and medical device experience joining our board. His industry knowledge and successful track record of growing medical technology businesses will be of great value to Thoratec as we pursue our growth strategies," said Gary F. Burbach, president and chief executive officer of Thoratec.

"I also want to acknowledge the contributions of those directors who are stepping down. Dr. J. Donald Hill, a founder of the company and a director since its inception, is a pioneer in the development and use of ventricular assist devices and played a major role at Thoratec throughout the history of the company. Howard Chase, who served as a director for more than 20 years, provided great counsel and support as the company became a leader in treating advanced stage heart failure," Burbach added.

Thoratec Corporation is a world leader in therapies to address advanced-stage heart failure.
'/>"/>

SOURCE Thoratec Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Thoratec Schedules Third Quarter Conference Call, Webcast
2. Thoratecs ITC Division Receives FDA Warning Letter
3. URGENT Thoratec Corporation Worldwide Recall of Implantable Ventricular Assist Device
4. Thoratec Announces Unanimous FDA Advisory Panel Recommendation for Approval of HeartMate II(R) for Bridge-to-Transplantation
5. Thoratec Schedules First Quarter 2008 Conference Call, Webcast
6. Thoratec Schedules Second Quarter 2008 Conference Call, Webcast
7. Thoratec Reports 44 Percent Increase in Second Quarter Revenues;
8. Thoratec Presentation at Piper Jaffary Conference to be Webcast
9. Thoratec Schedules Fiscal 2008 Year-End Conference Call, Webcast
10. Thoratec Reports 34 Percent Increase in 2008 Revenues
11. Thoratec Announces Definitive Agreement to Acquire HeartWare International For US$282 Million;
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... HealthDay Reporter , , MONDAY, May 20 (HealthDay News) -- ... are twice as likely to become obese adults as ... young, a new 30-year study shows. Researchers found ... higher body-mass index (BMI) and obesity, even if they ... no difference; well-off or poor, they tended toward ...
(Date:5/20/2013)... 2013 In celebration of National Women’s ... accomplishments achieved at The Feinstein Institute for Medical ... Advancing Women in Science and Medicine (AWSM) , ... Scientists, educators, business and community leaders from the ... of women in science. , “Women face unique ...
(Date:5/20/2013)... ANN ARBOR, Mich. As high schoolers prepare for ... a "study drug" -- a prescription stimulant or amphetamine ... University of Michigan poll shows only one in 100 ... teen has used a study drug., Study drugs refer ... attention deficit hyperactivity disorder (ADHD); commonly prescribed medicines in ...
(Date:5/20/2013)... Join Seva Foundation in celebrating its 35th Anniversary with ... Fine Arts Theater in San Francisco, featuring: Snatam ... with host Wavy Gravy. All proceeds will benefit Seva Foundation’s ... seats are $40 & $55, VIP tickets are $150 and ... row seat at the show. Tickets are available through ...
(Date:5/20/2013)... A new Benefits of Pharmacy Home Delivery ... of the MedEx Pack announced. The new ... Delivery, in order to provide useful details for those who ... Clyde Furuta, MedEx Direct owner and pharmacist said, “One of ... a product like the MedEx Pack, patients can receive their ...
Breaking Medicine News(10 mins):Health News:ADHD in Childhood May Raise Risk for Obesity in Adulthood 2Health News:ADHD in Childhood May Raise Risk for Obesity in Adulthood 3Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 2Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 3Health News:1 in 10 teens using 'study drugs,' but parents aren't paying attention 2Health News:Memorial Day Kirtan Concert Palace of Fine Arts Theater in San Francisco Featuring: Snatam Kaur, Jai Uttal, C.C. White & Shimshai with host Wavy Gravy,May 27th 7:00 PM 2Health News:Benefits of Pharmacy Home Delivery Report Published by MedEx Direct 2
... study finds , , FRIDAY, March 14 (HealthDay News) -- Higher ... harm older men, U.S. research shows. , A ... followed 1,000 seniors in three Florida retirement communities for up ... levels of anxiety at the start of the study lived ...
... Gottsch to Visit Washington, D.C., and Meet with Elected ... Boise,Idaho, will travel to Washington, D.C., this April 1 ... restoration of the,Americans with Disabilities Act, support for epilepsy ... epilepsy., Gottsch, 9, is one of 50 young ...
... Peter Serwik to Visit Washington, D.C., and Meet with ... of,Middletown, Del. will travel to Washington, D.C., this April ... for restoration of the,Americans with Disabilities Act, support for ... for epilepsy., Serwik, 7, is one of 50 ...
... C.J. Soeby to Visit Washington, D.C., and Meet With ... of Buckeye,Ariz. will travel to Washington, D.C., this April ... for restoration of the,Americans with Disabilities Act, support for ... for epilepsy., Soeby, 10, is one of 50 ...
... Washington, D.C., and Meet with Elected,Officials, WASHINGTON, March ... Washington, D.C., this April 1 to meet,with congressional leaders ... Disabilities Act, support for epilepsy public health,programs and more ... is one of 50 young people with epilepsy participating ...
... Washington, D.C., and Meet with Elected,Officials, WASHINGTON, March ... to Washington, D.C., this April 1 to meet,with congressional ... with Disabilities Act, support for epilepsy public health,programs and ... 16, is one of 50 young people with epilepsy ...
Cached Medicine News:Health News:Anxiety Helps Elderly Women Live Longer 2Health News:Idaho Youth Named National Epilepsy Spokesperson 2Health News:Delaware Youth Named National Epilepsy Spokesperson 2Health News:Arizona Youth Named National Epilepsy Spokesperson 2Health News:Vermont Youth Named National Epilepsy Spokesperson 2Health News:Virginia Youth Named National Epilepsy Spokesperson 2
(Date:5/20/2013)... 2013  Neuralstem, Inc. (NYSE MKT: CUR) today reported ... principal investigator, presented updated Phase I data from its ... the treatment of amyotrophic lateral sclerosis (ALS or ... diabetes special medical symposium in Bucharest, Romania ... Therapeutic Advances in Stem Cell Therapy," Dr. Feldman outlined ...
(Date:5/20/2013)... Mass. , May 20, 2013 ... and advisory firms for pharmaceutical and healthcare issues, ... that therapies offering a greater effect on quality ... unmet need. Given the high level of subjectivity ... of life, interviewed thought leaders state that it ...
(Date:5/19/2013)... Calif. , May 20, 2013  Whole-cell pertussis ... acellular pertussis vaccines during a large recent outbreak, according ... Whole-cell pertussis vaccines, also called DTwP, were ... with safety concerns that ultimately led to the development ... By the late 1990s, the United States ...
Breaking Medicine Technology:Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 2Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 3Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 4For Chronic Obstructive Pulmonary Disease, Surveyed Pulmonologists Indicate That Improved Effect on Quality of Life is One of the Greatest Unmet Needs 2Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 2Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 3Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 4
... ST. LOUIS, Oct. 20 Stereotaxis, Inc. (Nasdaq: ... launched the Odyssey Interventional Network, a training and ... cardiovascular community.  The portal will showcase innovative electrophysiology ... centers around the world.  The Odyssey Interventional Network ...
... 20 MAP Pharmaceuticals, Inc. (Nasdaq: MAPP ... nine analyses relating to its LEVADEX™ orally inhaled ... FREEDOM-301 Phase 3 trial, at the 2010 European ... Nice, France.  EHMTIC is a biennial congress of ...
Cached Medicine Technology:Stereotaxis Launches the Odyssey Interventional Network for Superior Online Cardiovascular Education and Training 2Stereotaxis Launches the Odyssey Interventional Network for Superior Online Cardiovascular Education and Training 3Stereotaxis Launches the Odyssey Interventional Network for Superior Online Cardiovascular Education and Training 4MAP Pharmaceuticals to Present Additional Data Analyses From LEVADEX™ FREEDOM-301 Trial at 2010 European Headache and Migraine Trust International Congress 2MAP Pharmaceuticals to Present Additional Data Analyses From LEVADEX™ FREEDOM-301 Trial at 2010 European Headache and Migraine Trust International Congress 3MAP Pharmaceuticals to Present Additional Data Analyses From LEVADEX™ FREEDOM-301 Trial at 2010 European Headache and Migraine Trust International Congress 4
... produce Type III, laboratory-grade pure water at ... directly with potable tap water and combine ... design that is easy to operate, reliable, ... produced at a low operating cost., Applications, ...
... systems produce Type III, laboratory-grade pure water ... fed directly with potable tap water and ... system design that is easy to operate, ... water produced at a low operating cost., ...
... chest freezer, with over 23 cu. ft. ... boxes. Built to the same standards as ... a cost-saving alternative. Rust-resistant, powder coated exterior; ... four adjustable shelves. Keyed lock and 4-digit ...
... Advanced Series CO2 Incubators by ... Microprocessor achieves precise temperature and ... evaporation & RH% is displayed ... and RH are displayed digiton ...
Medicine Products: